Bio-Techne (TECH) Finished Goods (2010 - 2026)
Bio-Techne's (TECH) quarterly Finished Goods came in at $111.9 million in Q1 2026, down 1.25% year-on-year from $113.3 million in Q1 2025, and down 2.57% quarter-over-quarter from $114.8 million in Q4 2025.
Bio-Techne (TECH) Finished Goods (2010 - 2026) Analysis & Trends
Bio-Techne's Finished Goods history runs 16 years deep, the most recent figure standing at $111.9 million for Q1 2026.
- On a quarterly basis, Finished Goods fell 1.25% year-over-year to $111.9 million in Q1 2026; TTM through Mar 2026 was $111.9 million, a 1.25% decrease from a year earlier, with the FY2025 full-year figure at $106.2 million, changed 0.11% from the prior year.
- Finished Goods eased to $111.9 million in Q1 2026 per TECH's latest filing, from $114.8 million in the prior quarter.
- Across five years, Finished Goods topped out at $114.9 million in Q3 2025 and bottomed at $66.9 million in Q2 2022.
- The 5-year median for Finished Goods is $106.1 million (2024), against an average of $100.4 million.
- Across the five-year window, Finished Goods soared 38.14% in 2023 and retreated 1.25% in 2026, its largest moves.
- Year by year, Finished Goods stood at $80.5 million in 2022, then gained by 27.76% to $102.9 million in 2023, then gained by 7.04% to $110.2 million in 2024, then increased by 4.26% to $114.8 million in 2025, then retreated by 2.57% to $111.9 million in 2026.
- Per Business Quant, the three latest TECH Finished Goods figures stand at $111.9 million (Q1 2026), $114.8 million (Q4 2025), and $114.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Bio-Techne | 11.23 Bn | 11.02 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 111.89 Mn |
| Dec 31, 2025 | 114.84 Mn |
| Sep 30, 2025 | 114.88 Mn |
| Jun 30, 2025 | 106.19 Mn |
| Mar 31, 2025 | 113.31 Mn |
| Dec 31, 2024 | 110.15 Mn |
| Sep 30, 2024 | 108.81 Mn |
| Jun 30, 2024 | 106.07 Mn |
| Mar 31, 2024 | 104.38 Mn |
| Dec 31, 2023 | 102.91 Mn |
| Sep 30, 2023 | 106.54 Mn |
| Jun 30, 2023 | 92.47 Mn |
| Mar 31, 2023 | 88.04 Mn |
| Dec 31, 2022 | 80.55 Mn |
| Sep 30, 2022 | 78.18 Mn |
| Jun 30, 2022 | 66.94 Mn |
| Jun 30, 2021 | 67.11 Mn |
| Mar 31, 2019 | 56.66 Mn |
| Dec 31, 2018 | 55.65 Mn |
| Sep 30, 2018 | 58.84 Mn |